Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011

Cancer

Volumn 121, Issue 20, 2015, Pages 3692-3699

  Ording, Anne G ^a   Horváth Puhõ, Erzsébet ^a   Lash, Timothy L ^a,b   Ehrenstein, Vera ^a   Borre, Michael ^a   Vyberg, Mogens ^c   Sørensen, Henrik T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b EMORY UNIVERSITY   (United States)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

comorbidity; epidemiology; hemostasis; morbidity; neoplasm grading; prostate cancer; pulmonary embolism; venous thrombosis

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DANISH CITIZEN; DENMARK; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REGISTER; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; VERY ELDERLY; COMPLICATION; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DENMARK; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84943584098     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29535     Document Type: Article

References (30)

1. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR,. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010; 8: 2105-2112.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B,. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380: 37-43.
3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49: 1374-1403.
4. Nguyen-Nielsen M, Norgaard M, Jacobsen JB, Borre M, Thomsen RW, Sogaard M,. Comorbidity and survival of Danish prostate cancer patients from 2000-2011: a population-based cohort study. Clin Epidemiol. 2013; 5 (suppl 1): 47-55.
5. Jespersen CG, Norgaard M, Bjerklund Johansen TE, Sogaard M, Borre M,. The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study [serial online]. BMC Cancer. 2011; 11: 519.
6. Daskivich TJ, Fan KH, Koyama T, et al., Effect of age, tumor risk, and comorbidity on competing risks for survival in a US population-based cohort of men with prostate cancer. Ann Intern Med. 2013; 158: 709-717.
7. Epstein MM, Edgren G, Rider JR, Mucci LA, Adami HO,. Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst. 2012; 104: 1335-1342.
8. Lyman GH,. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer. 2011; 117: 1334-1349.
9. Chaturvedi S, Sidana S, Elson P, Khorana AA, McCrae KR,. Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer [serial online]. PLoS One. 2014; 9: e94048.
10. Cronin-Fenton DP, Sondergaard F, Pedersen LA, et al., Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer. 2010; 103: 947-953.
11. Van Hemelrijck M, Adolfsson J, Garmo H, et al., Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol. 2010; 11: 450-458.
12. Frank L,. Epidemiology. when an entire country is a cohort. Science. 2000; 287: 2398-2399.
13. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB,. The Danish Civil Registration System. A cohort of 8 million persons. Dan Med Bull. 2006; 53: 441-449.
14. Gjerstorff ML,. The Danish Cancer Registry. Scand J Public Health. 2011; 39 (7 suppl): 42-45.
15. Drljevic A, Borre M, Høyer M, Ehrenstein V, Nugyen-Nielsen M,. Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients. Clin Epidemiol. 2014; 6: 351-357.
16. Lynge E, Sandegaard JL, Rebolj M,. The Danish National Patient Register. Scand J Public Health. 2011; 39 (7 suppl): 30-33.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
18. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT,. The predictive value of ICD-10 diagnostic coding used to assess Charlson Comorbidity Index conditions in the population-based Danish National Registry of Patients [serial online]. BMC Med Res Methodol. 2011; 11: 83.
19. Jespersen CG, Borre M, Norgaard M,. Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry. Clin Epidemiol. 2012; 4: 145-149.
20. Bjerregaard B, Larsen OB,. The Danish Pathology Register. Scand J Public Health. 2011; 39 (7 suppl): 72-74.
21. D'Amico AV, Whittington R, Malkowicz SB, et al., Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol. 2001; 166: 2185-2188.
22. Rothman KJ, Greenland S, Lash TL,. Concepts of interaction. In: Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: 71-86.
23. Van Hemelrijck M, Garmo H, Holmberg L, et al., Thromboembolic events following surgery for prostate cancer. Eur Urol. 2013; 63: 354-363.
24. Ehdaie B, Atoria CL, Gupta A, et al., Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer. 2012; 118: 3397-3406.
25. Hu JC, Williams SB, O'Malley AJ, Smith MR, Nguyen PL, Keating NL,. Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism. Eur Urol. 2012; 61: 1119-1128.
26. Prandoni P, Bilora F, Marchiori A, et al., An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003; 348: 1435-1441.
27. Johannesdottir SA, Horvath-Puho E, Dekkers OM, et al., Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med. 2013; 173: 743-752.
28. Schmidt M, Christiansen CF, Horvath-Puho E, Glynn RJ, Rothman KJ, Sorensen HT,. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost. 2011; 9: 1326-1333.
29. White RH, Zhou H, Romano PS,. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003; 90: 446-455.
30. Ganz PA, Barry JM, Burke W, et al., National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med. 2012; 156: 591-595.